QuantaSing Announces Unaudited Financial Results for the Second Quarter of Fiscal Year 2025
BEIJING, March 11, 2025 ( GLOBE NEWSWIRE ) -- QuantaSing Group Limited ( NASDAQ: QSG ) ( "QuantaSing" or the "Company" ) , a leading lifestyle solution provider empowering adults to live better and longer, today announced its unaudited financial results for the second quarter of the fiscal year ...
36Kr Holdings Inc. Reports Unaudited Financial Results for the Second Half and Fiscal Year 2024
BEIJING, March 11, 2025 ( GLOBE NEWSWIRE ) -- 36Kr Holdings Inc. ( "36Kr" or the "Company" or "We" ) ( NASDAQ: KRKR ) , a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced its unaudited financial results for the six months and ...
Oracle, Dick's Sporting Goods And 3 Stocks To Watch Heading Into Tuesday - Ciena ( NYSE:CIEN ) , Dick's Sporting Goods ( NYSE:DKS )
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects DICK'S Sporting Goods, Inc. DKS to report quarterly earnings at $3.53 per share on revenue of $3.78 billion before the opening bell, according ...
SalMar - Issuance of Commercial Paper
SalMar ASA ( rated BBB+ by Nordic Credit Rating ) has today issued a new commercial paper of NOK 1 000,000,000.
Dow Dips Nearly 900 Points As Recession Fears Grow; Investor Sentiment Decreases, Fear & Greed Index Remains In 'Extreme Fear' Zone - Ciena ( NYSE:CIEN ) , Dick's Sporting Goods ( NYSE:DKS )
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the "Extreme Fear" zone on Monday. U.S. stocks settled lower on Monday, with the Dow Jones index dipping around 900 points during the session.
Best Growth Stocks to Buy for March 11th
STRL, BGC, and DAN it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 11, 2025.
Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
SAN DIEGO, March 11, 2025 ( GLOBE NEWSWIRE ) -- Belite Bio, Inc ( NASDAQ: BLTE ) , a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will ...
